| 000 | 01261 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250513104126.0 | ||
| 264 | 0 | _c19970224 | |
| 008 | 199702s 0 0 eng d | ||
| 022 | _a0167-6997 | ||
| 024 | 7 |
_a10.1007/BF00210797 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aIngle, J N | |
| 245 | 0 | 0 |
_aOctreotide as first-line treatment for women with metastatic breast cancer. _h[electronic resource] |
| 260 |
_bInvestigational new drugs _c1996 |
||
| 300 |
_a235-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Agents, Hormonal _xadverse effects |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNeoplasm Metastasis |
| 650 | 0 | 4 |
_aOctreotide _xadverse effects |
| 650 | 0 | 4 |
_aTamoxifen _xadministration & dosage |
| 700 | 1 | _aKardinal, C G | |
| 700 | 1 | _aSuman, V J | |
| 700 | 1 | _aKrook, J E | |
| 700 | 1 | _aHatfield, A K | |
| 773 | 0 |
_tInvestigational new drugs _gvol. 14 _gno. 2 _gp. 235-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/BF00210797 _zAvailable from publisher's website |
| 999 |
_c8906345 _d8906345 |
||